{"task_id": "bf523b63dcad999e", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 30/464)", "text": "d valvular heart disease\n14\nPulmonary Hypertension\n\n--- Page 36 ---\nWHO CLASSIFICATION OF PULMONARY\nHYPERTENSION (CONT\u2019D)\nGROUP III. PULMONARY HYPERTENSION ASSO\nCIATED WITH HYPOXEMIA\nCOPD, interstitial\nlung disease, sleep disordered breathing, alveolar\nhypoventilation disorders, chronic exposure to high\naltitude, developmental abnormalities\nGROUP IV. PULMONARY HYPERTENSION DUE TO\nCHRONIC THROMBOTIC DISEASE, EMBOLIC DIS\nEASE, OR BOTH\nthromboembolic obstruction of\nproximalpulmonaryarteries,thromboembolicobstruc\ntion of distal pulmonary arteries, pulmonary embolism\n(tumor, parasites, foreign material)\nGROUP V. MISCELLANEOUS\nsarcoidosis, pulmon\nary Langerhans cell histiocytosis, lymphangiomatosis,\ncompression of pulmonary vessels (adenopathy,\ntumor, fibrosing mediastinitis)\nPATHOPHYSIOLOGY\nDEFINITION OF PULMONARY HYPERTENSION\nmean pulmonary arterial pressure (PAP) >25 mmHg\nat rest or mean PAP >30 mmHg with exercise mea\nsured with right heart catheterization\nCLINICAL FEATURES\nHISTORY\nunexplained\ndyspnea\non\nexertion,\ncough, chest pain, hemoptysis, dizziness, syncope,\nhoarseness, past medical history (cardiac and\nrespiratory diseases, thromboembolic diseases,\nHIV, cirrhosis, autoimmune and rheumatologic dis\norders), medications (amphetamine, diet pill such\nas dexfenfluramine)\nPHYSICAL\nvitals (tachypnea, tachycardia, atrial\nfibrillation, hypoxemia), peripheral cyanosis, small\npulse volume, elevated JVP (prominent a wave or\nabsent if atrial fibrillation, large v wave), right ventri\ncular heave, palpable P2, narrowly split or paradoxi\ncally split S2, right sided S4, tricuspid regurgitation\nCLINICAL FEATURES (CONT\u2019D)\nmurmur,\nGraham\nSteell\nmurmur\n(high pitched,\ndecrescendo diastolic rumble over LUSB), crackles,\ncongestive liver, ascites, ankle edema\nINVESTIGATIONS\nBASIC\n\u0002\nLABS\nCBCD, lytes, urea, Cr, AST, ALT, ALP, bilir\nubin, INR, albumin, ANA, RF, anti CCP, anti SCL\n70, anticentromere antibody, ESR, HIV serology,\nTSH\n\u0002\nIMAGING\nCXR, CT chest, V/Q scan or CT chest PE\nprotocol, echocardiogram\n\u0002 ECG\n\u0002\nOVERNIGHT POLYSOMNOGRAPHY\nif suspect OSA\n\u0002 ABG\n\u0002 PFT\nSPECIAL\n\u0002\nRIGHT HEART CATHETERIZATION\nMANAGEMENT\nSYMPTOM CONTROL\nO2, calcium channel blockers\nif positive vasoreactivity test (high doses), vasodilators\n(prostacyclin, sildenafil, bosentan, NO), anticoagulation\nTREAT UNDERLYING CAUSE\nATRIAL SEPTOSTOMY\nLUNG TRANSPLANT\nSPECIFIC ENTITIES\nEISENMENGER\nSYNDROME\nleft to right\nshunt\nleading to pulmonary hypertension and eventually\nright to left shunt\nTHYROTOXIC ASSOCIATED PULMONARY HYPER\nTENSION\npulmonary artery hypertension and iso\nlated right sided heart failure are associated with\nhyperthyroidism. Restoration to a euthyroid state\nmay reverse pulmonary hypertension\nInterstitial Lung Disease\nDIFFERENTIAL DIAGNOSIS\nPRIMARY (idiopathic)\nusual interstitial pneumo\nnia (UIP), respiratory bronchiolitis associated inter\nstitial lung disease (RBILD), desquamative intersti\ntial pneumonia (DIP), acute interstitial pneumonia\n(AIP), non specific interstitial pneumonia (NSIP),\nlymphoid interstitial pneumonia (LIP), cryptogenic\norganizing pneumonia (COP)\nSECONDARY wDICEw\n\u0002 DRUGS\nchemotherapy (bleomycin), sulfa, peni\ncillin, sulfonylurea, gold, penicillamine, pheny\ntoin, amiodarone, nitrofurantoin\nDIFFERENTIAL DIAGNOSIS (CONT\u2019D)\n\u0002 INFILTRATIVE\nlymphangitic\ncarcinomatosis,\nsarcoidosis\n\u0002 INFECTIONS\nTB,histoplasmosis,coccidioidomycosis\n\u0002 INFLAMMATORY\nrheumatoid arthritis, SLE, sclero\nderma, ankylosing spondylitis, myositis\n\u0002 CONGESTIVE HEART FAILURE\n\u0002 ENVIRONMENT\norganic\ndust\n(hypersensitivity\npneumonitis), inorganicdust (asbestos, silica, ber\nyllium, coal worker\u2019s pneumoconiosis)\n\u0002 EOSINOPHILIA-ASSOCIATED\nPULMONARY\nINFIL-\nTRATES\nallergic bronchopulmonary aspergillo\nsis (ABPA), parasitic, drugs\nInterstitial Lung Disease\n15", "text_length": 3751, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 30/464)", "type": "chunk", "chunk_index": 29, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.272762", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.273737", "status": "complete", "chunks_added": 2}